Email updates

Keep up to date with the latest news and content from Pediatric Rheumatology and BioMed Central.

This article is part of the supplement: 15th Paediatric Rheumatology European Society (PreS) Congress

Open Access Open Badges Poster presentation

Early untreated juvenile idiopathic arthritis: predictors of outcome

L Pascoli2*, S Blelock1, C Mc Allister2, S Clarke1, D Gibson1 and M Rooney1

  • * Corresponding author: L Pascoli

Author Affiliations

1 Queen's University Belfast, Belfast, UK

2 Musgrave Park Hospital, Belfast, UK

For all author emails, please log on.

Pediatric Rheumatology 2008, 6(Suppl 1):P118  doi:10.1186/1546-0096-6-S1-P118

The electronic version of this article is the complete one and can be found online at:

Published:15 September 2008

© 2008 Pascoli et al; licensee BioMed Central Ltd.


Currently there is little research into initiation and progression of JIA and there are no reliable predictors of outcome in early disease, resulting in suboptimal treatment.


We are undertaking a five-year prospective study of children with newly diagnosed and untreated JIA. At least one knee was involved requiring intra-articular steroid injection. Detailed clinical, imaging, and laboratory parameters were measured at T0 and 3/12 for 2 years. At outset we obtained synovial biopsies. We report the outcome on those children for whom data is available for one year.


At onset, of the first 32 children, 20 had oligoarticular (OJIA) disease. At one year, 2 had been reclassified as polyarticular (PJIA), 3 as extended oligo. Initially 9 had PJIA and, at 1 year, this increased to 11. At outset 2 had psoriatic, and 1 had enthesitis related arthritis.

At one year, all but 3 OJIA patients improved. Physician's global evaluation (PGE) and ANA status predicted recurrent synovitis at the biopsied joint, (p < 0.01) and (p < 0.02) respectively. PGE predicted the frequency of injections at any joint (p < 0.01).

At one year, all 11 with PJIA had improved clinical and laboratory parameters.

PJIA showed increased synovial pathology compared with OJIA (mean vessel score 6.9 vs. 2.6 (p < 0.05), mean B-cell score 1.7 vs. 1 (p < 0.05)).


In OJIA, PGE and ANA status predict recurrent synovitis. To date no correlation has been observed between histological findings and recurrent synovitis in OJIA. We will report on findings of our enlarged cohort who reach one year follow-up.